CRAIGAVON, Northern Ireland--(BUSINESS WIRE)--Almac announces the launch of its revolutionary new forecasting platform, COMPASS, which has been specifically designed to improve the accuracy and ...
Almac Group has today announced a $48 million investment in eClinical technologies that includes the launch of Almac Trial Coordinator™ – a first-in-class interoperable clinical trial technology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results